Since 2020, 8 of the 20 published clinical trials have focused on neurodevelopmental and neuropsychiatric/cognitive disorders, exhibiting a significant rise in clinical trials exploring sulforaphanes efficacy in the CNS compared to the previous two decades where only two of 57 trials focused on ASD alone with no published trials examining other CNS disorders (Supplementary Table 1)
The Future of Incretin-Based Therapy Understanding GLP-1 versus GIP provides context for where this field is heading
[DOI] [PubMed] [Google Scholar] 79.Gill K., Kirma N., Gunna V.S., Santanam N., Parthasarathy S., Tekmal R.R
Let the water trickle down the glass wall of the vial and pool at the bottom, gradually contacting the powder
Pros: Contains additional antioxidants like grape seed extract Halal-certified Available at major retailers like Watsons Cons: Lower glutathione dosage than premium options No third-party testing documentation Tablet form may have lower bioavailability 3